NMR-guided metabolomic evaluation of Aegle marmelos (L.) Correa: unveiling antihypertensive, antidiabetic, and anti-inflammatory activities
In Silico Pharmacology · 27.03.2026 · 14 (1)
DOI: 10.1007/s40203-026-00609-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Silico Pharmacology, online erschienen am 27.03.2026. Verfasst von Ritu Tiwari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India, 201002 Ghaziabad, India. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India, 201002 Ghaziabad, India.
- Alliance School of Biotechnology, Alliance University, Anekal, Bengaluru, 562106 India.
- Department of Pharmacognosy and Phytochemistry, Delhi Pharmaceutical Sciences and Research University, New Delhi, 110017 India.
Zitieren
APA
Tiwari, R., Chauhan, A. S., Dahiya, M., Dhobi, M., & Kalaiselvan, V. (2026). NMR-guided metabolomic evaluation of Aegle marmelos (L.) Correa: unveiling antihypertensive, antidiabetic, and anti-inflammatory activities. In Silico Pharmacology, 14(1). https://doi.org/10.1007/s40203-026-00609-4
Vancouver
Tiwari R, Chauhan AS, Dahiya M, Dhobi M, Kalaiselvan V. NMR-guided metabolomic evaluation of Aegle marmelos (L.) Correa: unveiling antihypertensive, antidiabetic, and anti-inflammatory activities. In Silico Pharmacology. 2026;14(1). doi:10.1007/s40203-026-00609-4
BibTeX
@article{Tiwari2026,
author = {Tiwari, Ritu and Chauhan, Aishwarya Singh and Dahiya, Meenakshi and Dhobi, Mahaveer and Kalaiselvan, V},
title = {NMR-guided metabolomic evaluation of Aegle marmelos (L.) Correa: unveiling antihypertensive, antidiabetic, and anti-inflammatory activities},
journal = {In Silico Pharmacology},
year = {2026},
volume = {14},
number = {1},
doi = {10.1007/s40203-026-00609-4}
}
EUVIMED